March 14, 2025

Enliven grew fourth-quarter R&D spending with trials underway

Enliven Therapeutics increased its research and development spending in the fourth quarter of fiscal 2024 as several drug trials are underway.

Related Posts

Sign up for BizWest Daily Alerts
Closing in 8 seconds...